[
    {
        "Field": "Evidence type",
        "Short description": "Evidence type based on the potential clinical actionability of the variant in a given disease.",
        "Example": "Prognostic",
        "Complete description": "Evidence type based on the potential clinical actionability or the pathogenicity of the variant in a given disease.",
        "Reference": null
    },
    {
        "Field": "Effect",
        "Short description": "Consequence of the variant observed during a clinical or functional investigation.",
        "Example": "Poor outcome",
        "Complete description": "Consequence of the variant observed during a clinical or functional investigation.",
        "Reference": null
    },
    {
        "Field": "Drug",
        "Short description": "Drug or combination of drugs",
        "Example": "Verumafenib",
        "Complete description": "Drug or combination of drugs used during a therapy",
        "Reference": ["Reference?"]
    },
    {
        "Field": "Tier Criteria",
        "Short description": "Level of pathogenicity or actionability of a variant as defined by AMP/ASCO/CAPS guidelines",
        "Example": "Clinical trial (Tier IID)",
        "Complete description": "Level of pathogenicity or actionability of a variant as defined by AMP/ASCO/CAPS guidelines. Precise => Tier criteria table to provide",
        "Reference": ["AMP/ASCO/CAPS guidelines"]
    },
    {
        "Field": "Mutation origin",
        "Short description": "Origin of the mutation (germline or somatic)",
        "Example": "Somatic",
        "Complete description": "Either inherited mutation (germline variant) or acquired mutation (somatic variant) using Sequence Ontology terms.",
        "Reference": ["http://www.sequenceontology.org/"]
    },
    {
        "Field": "Complementary information",
        "Short description": "Additional information for the interpretation of the variant provided during the curation/review process",
        "Example": "N.A.",
        "Complete description": "Additional information for the interpretation of the variant provided during the curation/review process",
        "Reference": null
    },
    {
        "Field": "Support",
        "Short description": "Curator/reviewer confidence of the published evidences (strong, moderate, low)",
        "Example": "Strong",
        "Complete description": "Curator/reviewer confidence of the published evidences, based on three levels: strong, moderate, low",
        "Reference": null
    },
    {
        "Field": "References",
        "Short description": "PMID, DOI or other.",
        "Example": "PMID: 24662454",
        "Complete description": "Pubmed ID, DOI or other type of reference used for the interpretation of the variant pathogenicity and actionability.",
        "Reference": null
    }
]
